Clinical, histopathological and immunohistochemical study of keratoacanthoma
Romanian Journal of Morphology and Embryology · 14.01.2022 · 62 (2) · 445-456
DOI: 10.47162/rjme.62.2.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Morphology and Embryology, online erschienen am 12.01.2022. Verfasst von Alina Maria Vîlcea und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Medicine and Pharmacy of Craiova, Romania; e-mail: tanaseloredanaelena@yahoo.com. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Keratoacanthoma, Skin Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Keratoacanthoma (KA) is an epithelial tumor of the skin, classically considered as having a malignant transformation risk of 15%; however, many authors and the new World Health Organization (WHO) Classification of skin tumors consider KA as an incipient variant of the cutaneous squamous cell carcinoma (SCC). The aims of the study were to assess the clinical, histopathological (HP) and immunohistochemical (IHC) aspects of the KA and the role of these factors in malignancy occurrence. The studied group comprises 194 patients diagnosed with KA or malignant KA, hospitalized in the Clinic of Dermatology, Emergency County Hospital, Craiova, Romania, between 2006 and 2019. There were 83 males and 111 females, aged 34 to 90 years, 57.21% of the patients being from the rural environment. The histopathology diagnosed 51 KAs and 143 malignant KAs (SCCs). Clinical diagnosis had a limited value in detecting the absence or presence of malignancy in the KA lesion, due to a low accuracy (36.08% and 29.89%, respectively) and specificity (23.07% and 27.02%, respectively); therefore, the HP exam of the surgical excision specimen has a paramount importance in establishing the diagnosis. IHC analysis revealed that the immunostainings for apoptosis-associated proteins and keratinocyte proliferative activity [p53, B-cell lymphoma-2 (Bcl-2), Ki-67 and proliferating cell nuclear antigen (PCNA)] provide some arguments to differentiate between KA and SCC in the studied cases. The correlation of clinical, HP and IHC data lead to an accurate diagnosis of KA; moreover, the clinical, HP and IHC data sustain the idea that KA is a particular form of well-differentiated SCC, which require an active therapeutic attitude.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, University of Medicine and Pharmacy of Craiova, Romania; e-mail: tanaseloredanaelena@yahoo.com.
Zitieren
APA
Vîlcea, A. M., Stoica, L. E., Georgescu, C. V., Popescu, F. C., Ciurea, R. N., Vîlcea, I. D., & Mirea, C. S. (2022). Clinical, histopathological and immunohistochemical study of keratoacanthoma. Romanian Journal of Morphology and Embryology, 62(2), 445-456. https://doi.org/10.47162/rjme.62.2.10
Vancouver
Vîlcea AM, Stoica LE, Georgescu CV, Popescu FC, Ciurea RN, Vîlcea ID, et al. Clinical, histopathological and immunohistochemical study of keratoacanthoma. Romanian Journal of Morphology and Embryology. 2022;62(2):445-456. doi:10.47162/rjme.62.2.10
BibTeX
@article{Vlcea2022,
author = {Vîlcea, Alina Maria and Stoica, Loredana Elena and Georgescu, Claudia Valentina and Popescu, Florina Carmen and Ciurea, Raluca Niculina and Vîlcea, Ionică Daniel and Mirea, Cecil Sorin},
title = {Clinical, histopathological and immunohistochemical study of keratoacanthoma},
journal = {Romanian Journal of Morphology and Embryology},
year = {2022},
volume = {62},
number = {2},
pages = {445--456},
doi = {10.47162/rjme.62.2.10}
}
EUVIMED